Plasmablastic Lymphoma Presenting With Rectosigmoid Perforation in a Human Immunodeficiency Virus-Positive Patient
- PMID: 35706759
- PMCID: PMC9187260
- DOI: 10.7759/cureus.24964
Plasmablastic Lymphoma Presenting With Rectosigmoid Perforation in a Human Immunodeficiency Virus-Positive Patient
Abstract
Plasmablastic lymphoma (PBL) is a rare variant of diffuse large B-cell lymphoma (DLBCL) associated with human immunodeficiency virus (HIV)-positive patients. It accounts for only 2% of all acquired immune deficiency syndrome (AIDS)-related lymphomas (ARLs). We present the case of a 45-year-old male who presented to the emergency department (ED) with a three-month history of abdominal pain, diarrhea, and unintentional 50-lb weight loss. On an earlier presentation to the ED three months prior, the patient was diagnosed with norovirus and Helicobacter pylori infection and received outpatient treatment without resolution of his symptoms. This prompted further investigation with a CT of the abdomen and pelvis with IV contrast that revealed severe sigmoid colitis with pneumoperitoneum and a pericolonic air-containing fluid collection, consistent with a contained perforation with abscess formation. He was admitted, resuscitated, and initially treated with antibiotics and parenteral nutrition. The patient underwent a laparoscopic converted to open anterior resection with end colostomy. Pathology revealed HIV-related PBL. He was subsequently treated with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (DA-EPOCH-R) chemotherapy regimen and an autologous stem cell transplant. Despite its rare association with HIV, PBL should be considered a differential diagnosis for HIV-positive patients who present with gastrointestinal (GI) pathology, and additional investigations should be conducted if symptoms do not resolve despite appropriate medical management at the time.
Keywords: hiv; open anterior resection; perforation; plasmablastic lymphoma; stem cell transplant.
Copyright © 2022, Zafar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




References
-
- Occurrence and prognosis of extranodal lymphomas. Freeman C, Berg JW, Cutler SJ. https://pubmed.ncbi.nlm.nih.gov/5007387/ Cancer. 1972;29:252–260. - PubMed
-
- Current knowledge on HIV-associated plasmablastic lymphoma. Bibas M, Castillo JJ. https://doi.org/10.4084/MJHID.2014.064 Mediterr J Hematol Infect Dis. 2014;6:0. - PMC - PubMed
-
- Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Castillo JJ, Winer ES, Stachurski D, et al. Leuk Lymphoma. 2010;51:2047–2053. - PubMed
-
- The biology and treatment of plasmablastic lymphoma. Castillo JJ, Bibas M, Miranda RN. http://org.proxy.cc.uic.edu/10.1182/blood-2014-10-567479. Blood. 2015;125:2323–2330. - PubMed
Publication types
LinkOut - more resources
Full Text Sources